Compare TLPH & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLPH | JFU |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 37.4M |
| IPO Year | 2010 | 2018 |
| Metric | TLPH | JFU |
|---|---|---|
| Price | $0.89 | $3.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 126.0K | 4.5K |
| Earning Date | 05-13-2026 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $1.25 |
| 52 Week High | $1.57 | $9.48 |
| Indicator | TLPH | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 55.42 |
| Support Level | $0.73 | $2.43 |
| Resistance Level | $1.02 | $4.80 |
| Average True Range (ATR) | 0.07 | 0.37 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 62.16 | 57.78 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.